- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05487144
Self-management EdUcation and SuPport to Promote PsychOsocial Health Among StRoke Survivors and Informal Caregivers in a VirTual Stroke Community (SUPPORT) (SUPPORT)
January 8, 2023 updated by: Jennifer Beauchamp, The University of Texas Health Science Center, Houston
Self-management EdUcation and SuPport to Promote PsychOsocial Health Among StRoke Survivors and Informal Caregivers in a VirTual Stroke Community (SUPPORT): A Pilot Project
The purpose of this study is to create a virtual stroke community for stroke survivors and informal caregivers of stroke survivors by customizing an existing VE intervention to incorporate real-time, stroke-specific, psychosocial self management education (SME) and social interactions, to test feasibility, acceptability, and usability of the customized intervention for stroke survivors and informal caregivers of stroke survivors and to obtain and explore data to derive evidence-based hypotheses and properly design and conduct a future, larger trial to demonstrate treatment efficacy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stroke survivors that have experienced an ischemic or hemorrhagic stroke event and their caregivers
- can read, write, and speak English
- are able to provide written consent
- are computer literate (have used a computer for ≥1 month)
- have access to a computer with broadband internet at home
- understand how to use the Internet (accessed the Internet on ≥2 occasions)
Exclusion Criteria:
- reside outside of the home
- Montreal Cognitive Assessment score of <9 indicating moderate to severe impairment
- Caregivers that provide long-distance care. I
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment
|
Phase 1 of the study will be a one-time meeting, either remote or in-person to complete V.E.
training and fill out questionnaires.
Phase 2 of the study is the 8 week intervention implementation.Participants will access the V.E.
community from their homes on a computer with broadband internet.
During the first four weeks of the intervention, participants will be required to come into the V.E. at least once per week for at least one hour.
For the last four weeks, V.E.
participation is strongly encouraged, but not required.
The content in the V.E. will focus on psychosocial health and stroke recovery, and the messaging in the VE will be updated bi-weekly to encourage retention and engagement.
Group meetings led by the study PI, a psychologist, or another trained member of the research team at least once a week will be offered.
During the intervention period, VE-specific data will be collected continuously.
Phase 3, will include a survey and a focus group interview via online platform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility as assessed by the number of participants enrolled in the study
Time Frame: post intervention (8 weeks from baseline of last participant )
|
This will be defined as the number enrolled divided by the number of eligible individuals screened
|
post intervention (8 weeks from baseline of last participant )
|
|
Feasibility as assessed by the number of participants who complete the study
Time Frame: post intervention (8 weeks from baseline of last participant )
|
post intervention (8 weeks from baseline of last participant )
|
|
|
Feasibility as assessed by the number of participants who complete the data collection forms
Time Frame: post intervention (8 weeks from baseline of last participant )
|
post intervention (8 weeks from baseline of last participant )
|
|
|
Usability as assessed by the perceived usefulness score
Time Frame: post intervention (8 weeks from baseline)
|
post intervention (8 weeks from baseline)
|
|
|
Usability as assessed by the perceived ease of use scores
Time Frame: post intervention (8 weeks from baseline)
|
This has 10 items, each scored form 1(strongly disagree) to 5(strongly agree), higher score meaning higher perceived ease of use
|
post intervention (8 weeks from baseline)
|
|
Usability as assessed by the number of times the participants log in
Time Frame: post intervention (8 weeks from baseline)
|
post intervention (8 weeks from baseline)
|
|
|
Usability as assessed by the time spent in the environment in minutes
Time Frame: post intervention (8 weeks from baseline)
|
post intervention (8 weeks from baseline)
|
|
|
Acceptability as assessed by the number of VE Meetings attended
Time Frame: post intervention (8 weeks from baseline)
|
post intervention (8 weeks from baseline)
|
|
|
Acceptability as assessed by the number of VE objects manipulated
Time Frame: post intervention (8 weeks form baseline)
|
Objects manipulated are the resources interacted with
|
post intervention (8 weeks form baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in perceived social support as assessed by the Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 12 item scale , each question is scored from 1(very strongly disagree) to 7(very strongly agree) for a maximum score of score of 84, a higher number indicating more social support
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in post stroke depression as assessed by the Patient Health Questionnaire-9 score (PHQ-9)
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 9 item questionnaire, each scored from 0(not at all) to 3(nearly every day), a higher number indication g more depression
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in anxiety as assessed by the Generalized Anxiety Disorder-7 score
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 7 item questionnaire, each is scored from 0(not at all) to 3(nearly every day) a higher number indicating more anxiety
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in loneliness as assessed by the UCLA loneliness scale scores
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 20 item questionnaire, each one is scored form 1(never) to 4(always).
Scores for questions 1,5,6,9,10,15,16,19 and 20 are reversed(i.e.
1=4,2=3,3=2,4=1)and the scores for each item is then summed together, higher number indicating more loneliness
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in caregiver burden as assessed by the Zarit Burden Interview (ZBI)
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 22 item questionnaire,each one scored from 0(never)-4(nearly always) higher core indicating more burden
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in self efficacy ( ability to perform tasks or behaviors) as assessed by the PROMIS General Self-efficacy Form
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 10 item questionnaire, each one is scored from 1(not at all true) to 4(exactly true), a higher number indicating a better outcome
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in emotional support as assessed by the NIH Emotional Support Form
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is an 8 item questionnaire, and each is scored form 1(never)-5(always), for a maximum score of 40, a higher number indicating higher levels of emotional support
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in instrumental support as assessed by the PROMIS Short Form v2.0
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is an 8 item questionnaire, and each is scored form 1(never)-5(always), for a maximum score of 40, a higher number indicating higher levels of instrumental support
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in ability to recover form stress as measured by the Brief Resilience Scale
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is a 6 item questionnaire scored from 1 (strongly disagree) to 5 (strongly agree) a higher number indicating a better outcome?
|
Baseline, post intervention (8 weeks after baseline)
|
|
Change in the amount that pain interferes with daily life as assessed by the PROMIS Short Form Pain Interference v 1.0 8a
Time Frame: Baseline, post intervention (8 weeks after baseline)
|
This is an 8 item questionnaire and each is scored from 1 (not at all) to 5 (very much) a higher number indicating a worse outcome
|
Baseline, post intervention (8 weeks after baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jennifer Beauchamp, PhD, RN, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 27, 2022
Primary Completion (Actual)
November 18, 2022
Study Completion (Actual)
November 18, 2022
Study Registration Dates
First Submitted
August 2, 2022
First Submitted That Met QC Criteria
August 2, 2022
First Posted (Actual)
August 4, 2022
Study Record Updates
Last Update Posted (Estimate)
January 10, 2023
Last Update Submitted That Met QC Criteria
January 8, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SN-21-1005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Learning in a Virtual Environment (LIVE)
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Inonu UniversityCompletedUniversity StudentsTurkey
-
University of ManitobaCompletedDementia | Spatial Navigation | Navigation, SpatialCanada
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
Ankara UniversityUniversity of DelawareCompletedPregnancy | SexualityTurkey (Türkiye)
-
Istanbul Medeniyet UniversityNot yet recruitingMachine Learning | Dangerous BehaviorTurkey
-
University Rehabilitation Institute, Republic of...CompletedMultiple Sclerosis | Parkinson DiseaseSlovenia
-
University Rehabilitation Institute, Republic of...European Regional Development Fund; Slovenian Research AgencyCompletedParkinson DiseaseSlovenia
-
Memorial University of NewfoundlandWithdrawnLaceration | Sutured Laceration
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)Completed